ÐÏࡱá>þÿ ‚þÿÿÿlÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿýÿÿÿ…  !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijkmýÿÿÿnopqrstuvwxyz{|}~€Root Entryÿÿÿÿÿÿÿÿ ÀF÷<ÿrf؃€WorkbookÿÿÿÿÿÿÿÿÿÿÿÿýETExtDataÿÿÿÿšSummaryInformation(ÿÿÿÿÿÿÿÿ Ì » ÍÁ€á°Áâ\p Administrator B°aÀ=¯¼=¡^±08X@�"·Ú1Ü�†‹[SO1Üÿ�†‹[SO1Üÿ�†‹[SO1Üÿ�†‹[SO1.Ü�Times New Roman1.Üÿ¼Times New Roman1.Ü�Times New Roman1.Üÿ�Times New Roman1Ü�†‹[SO1Ü �†‹[SO1Ü5�†‹[SO1Ü>�†‹[SO1h6¼†‹[SO1Ü ¼†‹[SO1Ü�†‹[SO1Ü�†‹[SO1Ü �†‹[SO1Ü �†‹[SO16¼†‹[SO1Ü6¼†‹[SO1Ü�†‹[SO1,6¼†‹[SO1Ü�†‹[SO1Ü?¼†‹[SO1Ü5¼†‹[SO1ܼ†‹[SO1Ü�†‹[SO1Üÿ¼†‹[SO1Ò�†‹[SO1.Ò�Times New Roman+"åÿ"#,##0;"åÿ"\-#,##05"åÿ"#,##0;[Red]"åÿ"\-#,##07"åÿ"#,##0.00;"åÿ"\-#,##0.00A"åÿ"#,##0.00;[Red]"åÿ"\-#,##0.00i*2_ "åÿ"* #,##0_ ;_ "åÿ"* \-#,##0_ ;_ "åÿ"* "-"_ ;_ @_ W))_ * #,##0_ ;_ * \-#,##0_ ;_ * "-"_ ;_ @_ y,:_ "åÿ"* #,##0.00_ ;_ "åÿ"* \-#,##0.00_ ;_ "åÿ"* "-"??_ ;_ @_ g+1_ * #,##0.00_ ;_ * \-#,##0.00_ ;_ * "-"??_ ;_ @_ /\$#,##0_);\(\$#,##0\)9\$#,##0_);[Red]\(\$#,##0\);\$#,##0.00_);\(\$#,##0.00\)E \$#,##0.00_);[Red]\(\$#,##0.00\)àõÿ@ @ À àõÿôÀ àõÿôÀ àõÿôÀ àõÿôÀ àõÿôÀ àõÿôÀ àõÿôÀ àõÿôÀ àõÿôÀ àõÿôÀ àõÿôÀ àõÿôÀ àõÿôÀ àõÿôÀ à@ @ À à*õÿø@ @ À àõÿ´@ @  à õÿ”— — / à,õÿø@ @ À à)õÿø@ @ À àõÿ´@ @  àõÿ´@ @ - à+õÿø@ @ À à õÿ´@ @  àõÿô@ @ À à õÿø@ @ À àõÿô@ @ À àõÿœ   à õÿ´@ @ / àõÿô@ @ À àõÿô@ @ À à õÿô@ @ À àõÿô@ @ À àõÿÔ @ @À àõÿÔ @ @À à õÿ´@ @ , àõÿÔ @ @À à õÿ´@ @ / àõÿ”¿¿ àõÿ”— —  àõÿ”ff¿¿7 àõÿ´@ @ * à õÿ´@ @ 5 à õÿÔ`@ @À àõÿÔa@ 0À àõÿ´@ @ * àõÿ´@ @ + àõÿ´@ @  à õÿ´@ @ 0 àõÿ´@ @  àõÿ´@ @  àõÿ´@ @  àõÿ´@ @ / à õÿ´@ @ 7 à õÿ´@ @ 3 àõÿ´@ @  àõÿ´@ @ + à õÿ´@ @ 6 àõÿ´@ @  à õÿ´@ @  à õÿ´@ @ 9 àõÿ´@ @  à õÿ´@ @  à@ @ À à1|@ @ À àx@ @ À àx@ @ À à8@ @ À à1|@ @ À àx@ @ À à8@ @ À àx@ @ À à8@ @ À à x@ @ À àx@ @ À àx@ @ À ||MZY;h}-} }}}A}ef }‘} ÿ ÿÿÿÿÌ™ÿ ??vÿ}}}}}A}ÌL }A}ÿÇÎÿ œÿ}}}A}23 }-} ÿÿ}}}-} €€ÿ}}} ²²²ÿ ²²²ÿ²²²ÿ²²²ÿÿÿÌÿ}A}23 }-} }-} ÿÿ}-}  }-}! ÿ}A}" }A}# }A}$23 }A}%ÿ? }A}&23 }‘}' ???ÿ ???ÿ???ÿ???ÿòòòÿ ???ÿ}‘}( ÿ ÿÿÿòòòÿ ú}ÿ}‘}) ???ÿ ???ÿ???ÿ???ÿ¥¥¥ÿ ÿÿÿÿ}A}*ef }A}+ }A},ÿ€ÿ ú}ÿ}U}- }A}.ÆïÎÿ aÿ}A}/ÿëœÿ œeÿ}A}0ef }A}1 }A}2ef }A}3ÌL }A}4ef }A}5ÌL }A}6 }A}7 }A}8ef }A}9ÌL }A}: }A};ÌL }A}<23 }A}= }A}>ÌL }A}?23 }-} }(}@ }(}D }(}F }(}G }(}H }(}J }(}K }(}L “€ÿ’’ÿ8^ĉ“€ÿ“!20% - :_Œ‡eW[œ˜r‚ 3’2’&ÿ20% - :_Œ‡eW[œ˜r‚ 3“ “�eQ’’ÿ“�eQ“€ÿ“€ÿ“!40% - :_Œ‡eW[œ˜r‚ 3’2’'ÿ40% - :_Œ‡eW[œ˜r‚ 3“î]’’ÿî]“€ÿ“!60% - :_Œ‡eW[œ˜r‚ 3’2’(ÿ60% - :_Œ‡eW[œ˜r‚ 3“€ÿ“€ÿ“€ ÿ“ èlÊ‘’’ ÿèlÊ‘“!60% - :_Œ‡eW[œ˜r‚ 2’2’$ÿ60% - :_Œ‡eW[œ˜r‚ 2“ h˜˜ 4’’ÿh˜˜ 4“ f‹JT‡e,g’’ ÿf‹JT‡e,g“ h˜˜’’ÿh˜˜“!ã‰Ê‘'`‡e,g’ ’5ÿã‰Ê‘'`‡e,g“ "h˜˜ 1’’ÿh˜˜ 1“ #h˜˜ 2’’ÿh˜˜ 2“!$60% - :_Œ‡eW[œ˜r‚ 1’2’ ÿ60% - :_Œ‡eW[œ˜r‚ 1“ %h˜˜ 3’’ÿh˜˜ 3“!&60% - :_Œ‡eW[œ˜r‚ 4’2’,ÿ60% - :_Œ‡eW[œ˜r‚ 4“ '“�úQ’’ÿ“�úQ“ (¡‹—{’’ÿ¡‹—{“)ÀhågUSCQ40% - :_Œ‡eW[œ˜r‚ 6’2’3ÿ40% - :_Œ‡eW[œ˜r‚ 6“!?60% - :_Œ‡eW[œ˜r‚ 6’2’4ÿ60% - :_Œ‡eW[œ˜r‚ 6cc–Í –PK ‡Nâ@theme/PK ‡Nâ@ theme/theme/PK‡Nâ@ky–}Štheme/theme/themeManager.xml ÌM à @á}¡w�Ù7c»(Eb²Ë®»öCœAÇ ÒŸÛ×åãƒ7ÎßÕ›K Y,œ ŠeÍ.ˆ·ð|,§¨ÚHÅ,láÇæéxÉ´�ßIÈsQ}#Õ�…­µÝ Öµ+Õ!ï,Ý^¹$j=‹GWèÓ÷)âEë+& 8ýPK‡Nâ@L–ÐÛ theme/theme/theme1.xmlíYMo7½èX콑dë#2"¶>â&vDJŠ©]j—w¹ );ºɱ@�¢iÑK�Þz(ÚH€^Ò_ã6E›ù rW+R¢jÇÈ!-b_$î›áãÌ𠹺rõaB½cÌaiǯ]ªúN’4êøwGƒ�.ûž�( e)îøs,ü«»~píÈ'ØûTì ŽK™íT*"€a$.± §ðlÂx‚$|åQ%äèü&´²U­6+ "©ï¥(··&`wá¶OÁw*…(*§xNk !æ¢K¹wŒhLJBv2Â¥ïQ$$<èøUýçWv¯TÐNaDå[Ãn ÿ »Â œné9y4.'­×õæ^é_¨\Çõ[ýf¿YúÓ°Òœ‹é³±ßÞï5 ¬Ê?:|÷Z½íš…7üo¯qÞk¨ ¯A¹ÿú~0èB-¼åøÆ¾^omuë^ƒr|s ߪîõê- ¯A1%ét ]m4·»‹Õ–� £Nx»Q´¶ çKTCY]jŠ Kå¦ZKÐÆP@Š$I=9ÏðP¿]Dɘï�D±TÓ ŒŒçùP Ö†ÔŒž8ÉdÇ¿ž!ØK¯¯_üøúÅ3ïõ‹§§�žŸ>úåôñãÓG?ç¾,ÔF¦á«ï¿øûÛO½¿ž}÷êÉWn¼0ñ¿ÿôÙo¿~éÂ>Z2zùõÓ?ž?}ùÍçþðÄßãhlÂG$Á»‰O¼;,�µéÀØÌñ˜¿™Å(FIJ@1øv¸îËØÞœ#êÂíc;x÷8Hˆ xmöÀâ:ŒùLÇÌ7âÄ1F÷wà†šËˆðh–FîÉùÌÄÝAèØ5w¥Vjû³ ´“¸\vclѼMQ*Q„S,=õŒM1v¬î>!V\�HÀ™`éÝ'Þ>"Î�ŒÈØ*¤¥ÑI /sAHµ›£{Þ>£®U÷ð±�„ �¨ƒüS+Œ×ÐL¢Äår„jüÉØEr8ç�‰ë ™Ž0e^?ÄB¸lnqX¯‘ô î´Ñyb#¹$S—ÏCʉì±i7FIæÂI›Ø�ÅJy·™tÁ�˜½CÔwÈJ7¦ûÁVºÏ‚» œ&¥e�¨'3îÈå5̬úÎéa­2 ì–^'$=S¼óÞËvÇßãĹyVÄzî?(Ñ=4KocØë-ê½B¿Whÿ¯Ð›öòÛ×奃J«Ã`~âÖçïdãñ{B(Ê9ŇBŸÀ4 pƒÊN_:qyËbø¨v2L`á"Ž´�Ç™ü„Èx£ Nï5_9‰Dá:^ÆÜõ°Ó·ÂÓYrÄÂüÖY«©f.ÉåxµQŽÃ�Aæèfky“*Ýk¶‘¾ñ.(Û7!aLf“Øv�h-U�ôý‚æ ¡WöVX´,.+÷‹T­±jeVà„äÁ¹ªã7ê`FpmB‡*OyªÙÕÉ|›™ÞL«ªðR£¨€e¦ÛŠëÆå©Õå¥vŽL[$Œr³IèÈè&bâ¢:Õèyh¼i®ÛË”ZôT(ŠX4Z—ÿ�ÅEs v«Ú@SS)hê�tüævJ&@YÇŸÀí>&ÔŽP'[D#xùHžoø‹(KÆ…ì!ç×¢“«AB$æ%IÇWË/Ó@S­!š[m á�%×Yy×ÈAÒí$ãÉÒL»1¢"�…ϵÂùT›_¬,Ù Ò=ŒÃoLgü‚k´j*€!ðŠ§–G3$ðV²²eý­4¦BvÍׂº†òqD³Å󮥼¤£¿•10¾k†€!)á8R Ö ªÕMË®‘sØØuÏ6R‘3DsÙ3-UQ]Ó­bÖ ‹6°Ë‹5yƒÕ"ÄÐ.ÍŸK÷ªä¶Z·rN(»¼ŒŸ£ëž£!Ô–“YÔãuVš]ŒÚ½c±À3¨�§Iªß\¸]‰[Ù#œÓÁà…:?Ø­V- MçJiýÃ…ù ?ñèÁ»Ü•" ÚýPK ‡Nâ@_rels/PK‡Nâ@¥Ö§çº6 _rels/.rels…�ÏjÃ0 ‡ï…½ƒÑ}QÒÃ%v/¥�C/£}á(h"ÛëÛOÇ »„¤ï÷©=þ®‹ùá”ç šªÃâC?Ëháv=¿‚É…¤§%[xp†£{Ûµ_¼PÑ£<Í1¥H¶0•ˆÙO¼R®BdÑÉÒJEÛ4b$§‘q_טžà6LÓõR×7`®�¨Éÿ³Ã0ÌžOÁ¯,åEn7”Liäb¡¨/ãS½�¨eªÔе¸ùÖýPK ‡Nâ@theme/theme/_rels/PK‡Nâ@ Ñ�Ÿ¯'theme/theme/_rels/themeManager.xml.rels…�M Â0„÷‚wooÓº‘&݈ЭÔ„ä5 6?$Qìí ®,.‡a¾™i»—�Éc2Þ1hª:é•qšÁm¸ìŽ@RN‰Ù;d°`‚Žo7íg‘K(M&$R(.1˜r'J“œÐŠTù€®8£�Vä"£¦AÈ»ÐH÷u} ñ›|Å$½b{Õ–Pšÿ³ý8‰g/]þQAsÙ…(¢ÆÌà#›ªLÊ[ººÄßPK‡Nâ@ ¬$Òø[Content_Types].xml­‘ËNÃ0E÷Hüƒå-Jœ²@%é‚ÇŽÇ¢|ÀÈ™$ÉØ²§Uû÷LÒTB¨ l,Ùã¹çx\®÷ã v“óTéU^h…d}㨫ôûæ)»Õ*1Pƒ'¬ô“^×—åæ0)é¦Též9Ü“l�#¤Ü$©´>ŽÀ²�� `? Cs]7Æzb$ÎxÊÐuù€-lV�{9>šD’V÷Ç‹«ÒÂà,°˜š5ß(ÙBÈ¥s¾“zÒ•hhs–0U~,}¯2šèToùFÑ0,�įë*ÿ=댬o[g±ñv;Ê ò9òäú'æ3�Œ3þy ; ˜ùoëOPK‡Nâ@ ¬$Òø ? [Content_Types].xmlPK ‡Nâ@_rels/PK‡Nâ@¥Ö§çº6  8_rels/.relsPK ‡Nâ@theme/PK ‡Nâ@ $theme/theme/PK ‡Nâ@theme/theme/_rels/PK‡Nâ@ Ñ�Ÿ¯' Ktheme/theme/_rels/themeManager.xml.relsPK‡Nâ@L–ÐÛ  theme/theme/theme1.xmlPK‡Nâ@ky–}Š Ntheme/theme/themeManager.xmlPK ?h ŒŒŽXŽ�TableStyleMedium2PivotStyleLight16`….MÑdocumentsexport (1)ššŒVVÁÁ�4ü x �^÷S ‡eàz˜˜ T b!h\O€ úQY f[Ñy «ˆ_!kpe úQHrt^DALIROCUMAB AND CARDIOVASCULAR OUTCOMES AFTER ACUTE CORONARY SYNDROME Lin, Jinxiu?NEW ENGLAND JOURNAL OF MEDICINE 379 (22): 2097-2107 NOV 29 2018CLINICAL MEDICINEÃRANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE III TRIAL OF APATINIB IN PATIENTS WITH CHEMOTHERAPY-REFRACTORY ADVANCED OR METASTATIC ADENOCARCINOMA OF THE STOMACH OR GASTROESOPHAGEAL JUNCTION Lin, Xiaoyan7JOURNAL OF CLINICAL ONCOLOGY 34 (13): 1448-+ MAY 1 2016lCHANGING CANCER SURVIVAL IN CHINA DURING 2003-15: A POOLED ANALYSIS OF 17 POPULATION-BASED CANCER REGISTRIES Zhou, Yan;.LANCET GLOBAL HEALTH 6 (5): E555-E567 MAY 2018‰SOAPNUKE: A MAPREDUCE ACCELERATION-SUPPORTED SOFTWARE FOR INTEGRATED QUALITY CONTROL AND PREPROCESSING OF HIGH-THROUGHPUT SEQUENCING DATAShi, Chunmei;Chen, QiangGIGASCIENCE 7 (1): - DEC 4 2017COMPUTER SCIENCE„MORBIDITY AND MORTALITY OF LAPAROSCOPIC VERSUS OPEN D2 DISTAL GASTRECTOMY FOR ADVANCED GASTRIC CANCER: A RANDOMIZED CONTROLLED TRIAL' Huang,Changming;Zheng, Chaohui;Li, Ping  8JOURNAL OF CLINICAL ONCOLOGY 34 (12): 1350-+ APR 20 2016gGENETIC ANALYSIS OF OVER 1 MILLION PEOPLE IDENTIFIES 535 NEW LOCI ASSOCIATED WITH BLOOD PRESSURE TRAITS Ren, Meixia(NATURE GENETICS 50 (10): 1412-+ OCT 2018MOLECULAR BIOLOGY & GENETICSIASSESSING THE STABILITY OF HUMAN LOCOMOTION: A REVIEW OF CURRENT MEASURES Bruijn, S. M.;Meijer, O. G. <JOURNAL OF THE ROYAL SOCIETY INTERFACE 10 (83): - JUN 6 2013}GENOME-WIDE ASSOCIATION ANALYSIS IDENTIFIES NOVEL BLOOD PRESSURE LOCI AND OFFERS BIOLOGICAL INSIGHTS INTO CARDIOVASCULAR RISK(NATURE GENETICS 49 (3): 403-415 MAR 2017«GEFITINIB VERSUS VINORELBINE PLUS CISPLATIN AS ADJUVANT TREATMENT FOR STAGE II-IIIA (N1-N2) EGFR-MUTANT NSCLC (ADJUVANT/CTONG1104): A RANDOMISED, OPEN-LABEL, PHASE 3 STUDY Chen, Chun(LANCET ONCOLOGY 19 (1): 139-148 JAN 2018gTHE IMPACT OF COPD AND SMOKING HISTORY ON THE SEVERITY OF COVID-19: A SYSTEMIC REVIEW AND META-ANALYSIS2Wu, Yinlian;Huang, Jiaofeng;Lian, Ningfang;Lin, Su7JOURNAL OF MEDICAL VIROLOGY 92 (10): 1915-1921 OCT 2020 MICROBIOLOGYFFIBRINOGEN-LIKE PROTEIN 1 IS A MAJOR IMMUNE INHIBITORY LIGAND OF LAG-3&Chen, Ling;Chen, Yusheng;Chen, Lieping!CELL 176 (1-2): 334-+ JAN 10 2019©EFFECT OF LAPAROSCOPIC VS OPEN DISTAL GASTRECTOMY ON 3-YEAR DISEASE-FREE SURVIVAL IN PATIENTS WITH LOCALLY ADVANCED GASTRIC CANCER THE CLASS-01 RANDOMIZED CLINICAL TRIALHuang, ChangmingPJAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION 321 (20): 1983-1992 MAY 28 20196ACUTE KIDNEY INJURY IN CHINA: A CROSS-SECTIONAL SURVEYLiu, Xiaohua;Pan, Miao)LANCET 386 (10002): 1465-1471 OCT 10 2015FTREM2 IS A RECEPTOR FOR BETA-AMYLOID THAT MEDIATES MICROGLIAL FUNCTION Wu, Xilin;Chen, Xiaochun  NEURON 97 (5): 1023-+ MAR 7 2018NEUROSCIENCE & BEHAVIORKWEGO 2.0: A WEB TOOL FOR ANALYZING AND PLOTTING GO ANNOTATIONS, 2018 UPDATE Chen, Qiang; Shi, Chunmei;  2NUCLEIC ACIDS RESEARCH 46 (W1): W71-W75 JUL 2 2018BIOLOGY & BIOCHEMISTRYOENDOVASCULAR THROMBECTOMY WITH OR WITHOUT INTRAVENOUS ALTEPLASE IN ACUTE STROKE Chen, Wenhuo?NEW ENGLAND JOURNAL OF MEDICINE 382 (21): 1981-1993 MAY 21 2020.STANDARDS OF CARE FOR TYPE 2 DIABETES IN CHINA Yang, LiyongMDIABETES-METABOLISM RESEARCH AND REVIEWS 32 (5): 442-458 SP. ISS. SI JUL 2016üMODIFIED FOLFOX6 WITH OR WITHOUT RADIATION VERSUS FLUOROURACIL AND LEUCOVORIN WITH RADIATION IN NEOADJUVANT TREATMENT OF LOCALLY ADVANCED RECTAL CANCER: INITIAL RESULTS OF THE CHINESE FOWARC MULTICENTER, OPEN-LABEL, RANDOMIZED THREE-ARM PHASE III TRIAL Chi, Pan;8JOURNAL OF CLINICAL ONCOLOGY 34 (27): 3300-+ SEP 20 2016\GENETIC EPIDEMIOLOGY OF AMYOTROPHIC LATERAL SCLEROSIS: A SYSTEMATIC REVIEW AND META-ANALYSISHZou, Zhang-Yu; Che, Chun-Hui; Liu, Chang-Yun; He, Rao-Li; Huang, Hua-PinIJOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY 88 (7): 540-549 JUL 20177A ROLE FOR TUBULAR NECROPTOSIS IN CISPLATIN-INDUCED AKI Xu, YanfangIJOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY 26 (11): 2647-2658 NOV 2015ZGUIDELINES FOR THE USE AND INTERPRETATION OF ASSAYS FOR MONITORING AUTOPHAGY (4TH EDITION) Wang, ZhenyuAUTOPHAGY 17 (1): 1-38< 2 2021 DOUBLE PHOTOSYSTEMS-BASED Z-SCHEME PHOTOELECTROCHEMICAL SENSING MODE FOR ULTRASENSITIVE DETECTION OF DISEASE BIOMARKER ACCOMPANYING THREE-DIMENSIONAL DNA WALKER Zeng, Yongyi2ANALYTICAL CHEMISTRY 90 (11): 7086-7093 JUN 5 2018 CHEMISTRY§ASSOCIATION BETWEEN CYP2C19 LOSS-OF-FUNCTION ALLELE STATUS AND EFFICACY OF CLOPIDOGREL FOR RISK REDUCTION AMONG PATIENTS WITH MINOR STROKE OR TRANSIENT ISCHEMIC ATTACKLin, Yi;JJAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION 316 (1): 70-78 JUL 5 2016;STANDARDS OF MEDICAL CARE FOR TYPE 2 DIABETES IN CHINA 2019;DIABETES-METABOLISM RESEARCH AND REVIEWS 35 (6): - SEP 2019yLYMPHOPENIA IS ASSOCIATED WITH SEVERE CORONAVIRUS DISEASE 2019 (COVID-19) INFECTIONS: A SYSTEMIC REVIEW AND META-ANALYSIS)Wu, Yinlian;Huang, Jiaofeng;Weng, ZhiyuanAINTERNATIONAL JOURNAL OF INFECTIOUS DISEASES 96: 131-135 JUL 2020 IMMUNOLOGY^METAL-POLYDOPAMINE FRAMEWORK: AN INNOVATIVE SIGNAL-GENERATION TAG FOR COLORIMETRIC IMMUNOASSAY5ANALYTICAL CHEMISTRY 90 (18): 11099-11105 SEP 18 2018rA VISIBLE AND COLORIMETRIC APTASENSOR BASED ON DNA-CAPPED SINGLE-WALLED CARBON NANOTUBES FOR DETECTION OF EXOSOMEScXia, Yaokun;Liu, Mengmeng;Wang, Liangliang;Yan, An;He, Wenhui;Chen, Mei;Lan, Jianming;Chen, Jinghua0BIOSENSORS & BIOELECTRONICS 92: 8-15 JUN 15 2017:PRECISION DIAGNOSIS AND TREATMENT OF LIVER CANCER IN CHINAFu, Jing&CANCER LETTERS 412: 283-288 JAN 1 2018…PROPOSAL FOR THE 8TH EDITION OF THE AJCC/UICC STAGING SYSTEM FOR NASOPHARYNGEAL CANCER IN THE ERA OF INTENSITY-MODULATED RADIOTHERAPY9Pan, Jian Ji;Zong, Jing Feng;Lin, Shao Jun;Guo, Qiao Juan#CANCER 122 (4): 546-558 FEB 15 2016ßOMEGA-3 POLYUNSATURATED FATTY ACID ATTENUATES THE INFLAMMATORY RESPONSE BY MODULATING MICROGLIA POLARIZATION THROUGH SIRT1-MEDIATED DEACETYLATION OF THE HMGB1/NF-KAPPA B PATHWAY FOLLOWING EXPERIMENTAL TRAUMATIC BRAIN INJURY]Chen, Xiangrong;Chen, Chunnuan;Fan, Sining;Wu, Shukai;Yang, Fuxing;Fang, Zhongning;Li, Yasong.JOURNAL OF NEUROINFLAMMATION 15: - APR 20 2018»OMEGA-3 POLYUNSATURATED FATTY ACID SUPPLEMENTATION ATTENUATES MICROGLIAL-INDUCED INFLAMMATION BY INHIBITING THE HMGB1/TLR4/NF-KAPPA B PATHWAY FOLLOWING EXPERIMENTAL TRAUMATIC BRAIN INJURYiChen, Xiangrong;Wu, Shukai;Chen, Chunnuan;Xie, Baoyuan;Fang, Zhongning;Hu, Weipeng;Chen, Junyan;He, Hefan.JOURNAL OF NEUROINFLAMMATION 14: - JUL 24 2017—DUAL-CHANNEL PHOTOELECTROCHEMICAL RATIOMETRIC APTASENSOR WITH UP-CONVERTING NANOCRYSTALS USING SPATIAL-RESOLVED TECHNIQUE ON HOMEMADE 3D PRINTED DEVICE Liu, Jingfeng2ANALYTICAL CHEMISTRY 91 (2): 1260-1268 JAN 15 2019XUNDERSTANDING COVID-19 VACCINE DEMAND AND HESITANCY: A NATIONWIDE ONLINE SURVEY IN CHINA*Lin, Yulan;Hu, Zhijian; Wong, Li Ping4PLOS NEGLECTED TROPICAL DISEASES 14 (12): - DEC 2020EINCIDENCE AND ETIOLOGY OF DRUG-INDUCED LIVER INJURY IN MAINLAND CHINA Yao, Lvfeng)GASTROENTEROLOGY 156 (8): 2230-+ JUN 20194APPLICATION OF PD-1 BLOCKADE IN CANCER IMMUNOTHERAPYChen, Wei; Liu, XiaolongCCOMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL 17: 661-674 2019—COMPARISON OF [GA-68]GA-DOTA-FAPI-04 AND [F-18] FDG PET/CT FOR THE DIAGNOSIS OF PRIMARY AND METASTATIC LESIONS IN PATIENTS WITH VARIOUS TYPES OF CANCERš Chen, HaojunÿPang, YizhenÿWu, JingxunÿZhao, LiangÿHao, BingÿWu, JingÿWei, JihongÿWu, SimingÿZhao, LongÿLuo, ZuomingÿLin, XuehuaÿSun, LongÿLin, QinÿWu, Hua  %&12;<DEPQ[\fgst€‰Š’“UEUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING 47 (8): 1820-1832 JUL 2020CLINICAL CHARACTERISTICS OF NON-ICU HOSPITALIZED PATIENTS WITH CORONAVIRUS DISEASE 2019 AND LIVER INJURY: A RETROSPECTIVE STUDYTXie, Hansheng; Zhao, Jianming; Lian, Ningfang; Lin, Su; Xie, Qunfang; Zhuo, Huichang.LIVER INTERNATIONAL 40 (6): 1321-1326 JUN 2020˜CAMRELIZUMAB IN PATIENTS WITH PREVIOUSLY TREATED ADVANCED HEPATOCELLULAR CARCINOMA: A MULTICENTRE, OPEN-LABEL, PARALLEL-GROUP, RANDOMISED, PHASE 2 TRIAL(LANCET ONCOLOGY 21 (4): 571-580 APR 2020›FROM SARS AND MERS TO COVID-19: A BRIEF SUMMARY AND COMPARISON OF SEVERE ACUTE RESPIRATORY INFECTIONS CAUSED BY THREE HIGHLY PATHOGENIC HUMAN CORONAVIRUSESRZhu, Zhixing;Lian, Xihua;Su, Xiaoshan;Wu, Weij< ing;Marraro, Giuseppe A;Zeng, Yiming*RESPIRATORY RESEARCH 21 (1): - AUG 27 2020ÎSAFETY, EFFICACY AND TUMOR MUTATIONAL BURDEN AS A BIOMARKER OF OVERALL SURVIVAL BENEFIT IN CHEMO-REFRACTORY GASTRIC CANCER TREATED WITH TORIPALIMAB, A PD-1 ANTIBODY IN PHASE IB/II CLINICAL TRIAL NCT02915432 Lin, X.Y.-ANNALS OF ONCOLOGY 30 (9): 1479-1486 SEP 2019?COMPARISON OF MAFLD AND NAFLD DIAGNOSTIC CRITERIA IN REAL WORLDjLin, Su;Huang, Jiaofeng;Wang, Mingfang; Liu, Yuxiu;Liu, Shiying; Wu, Yinlian; Wang, Xiaozhong;Zhu, Yueyong.LIVER INTERNATIONAL 40 (9): 2082-2089 SEP 2020uCHITOSAN-STABILIZED PLATINUM NANOPARTICLES AS EFFECTIVE OXIDASE MIMICS FOR COLORIMETRIC DETECTION OF ACID PHOSPHATASEYDeng, Haohua;Lin, Xiuling;Li, Kelin;Zhuang, Qiongqiong;Peng, Huaping;Liu, Ailin;Chen, Wei(NANOSCALE 9 (29): 10292-10300 AUG 7 2017PHYSICS‰RISK FACTORS, PATTERNS, AND OUTCOMES OF LATE RECURRENCE AFTER LIVER RESECTION FOR HEPATOCELLULAR CARCINOMA A MULTICENTER STUDY FROM CHINA Zeng, Yong-Yi&JAMA SURGERY 154 (3): 209-217 MAR 2019\EFFECT OF ALIROCUMAB ON LIPOPROTEIN(A) AND CARDIOVASCULAR RISK AFTER ACUTE CORONARY SYNDROMEIJOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY 75 (2): 133-144 JAN 21 2020ÄERLOTINIB VERSUS VINORELBINE PLUS CISPLATIN AS ADJUVANT THERAPY IN CHINESE PATIENTS WITH STAGE IIIA EGFR MUTATION-POSITIVE NON-SMALL-CELL LUNG CANCER (EVAN) A RANDOMISED, OPEN-LABEL, PHASE 2 TRIAL4LANCET RESPIRATORY MEDICINE 6 (11): 863-873 NOV 2018eEPIDEMIOLOGY OF CARBAPENEM-RESISTANT ENTEROBACTERIACEAE INFECTIONS: REPORT FROM THE CHINA CRE NETWORKHuang, Jiaming8ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 62 (2): - FEB 2018PHARMACOLOGY & TOXICOLOGYvDEVELOPMENT OF DIAGNOSTIC CRITERIA AND A PROGNOSTIC SCORE FOR HEPATITIS B VIRUS-RELATED ACUTE-ON-CHRONIC LIVER FAILURE Pan, ChenGUT 67 (12): 2181-2191 DEC 2018�IMPACT OF CORTICOSTEROID THERAPY ON OUTCOMES OF PERSONS WITH SARS-COV-2, SARS-COV, OR MERS-COV INFECTION: A SYSTEMATIC REVIEW AND META-ANALYSISWang, Jiaojiao#LEUKEMIA 34 (6): 1503-1511 JUN 2020�REGULATORY NETWORK OF CIRCRNA-MIRNA-MRNA CONTRIBUTES TO THE HISTOLOGICAL CLASSIFICATION AND DISEASE PROGRESSION IN GASTRIC CANCER Cai, Jianchun2JOURNAL OF TRANSLATIONAL MEDICINE 16: - AUG 2 2018ÎEFFECTS OF ALIROCUMAB ON CARDIOVASCULAR AND METABOLIC OUTCOMES AFTER ACUTE CORONARY SYNDROME IN PATIENTS WITH OR WITHOUT DIABETES: A PRESPECIFIED ANALYSIS OF THE ODYSSEY OUTCOMES RANDOMISED CONTROLLED TRIAL7LANCET DIABETES & ENDOCRINOLOGY 7 (8): 618-628 AUG 2019�CONSENSUS OF CHINESE EXPERTS ON PROTECTION OF SKIN AND MUCOUS MEMBRANE BARRIER FOR HEALTH-CARE WORKERS FIGHTING AGAINST CORONAVIRUS DISEASE 2019 Cheng, Bo'DERMATOLOGIC THERAPY 33 (4): - JUL 2020€CIRCULAR RNAS NEGATIVELY REGULATE CANCER STEM CELLS BY PHYSICALLY BINDING FMRP AGAINST CCAR1 COMPLEX IN HEPATOCELLULAR CARCINOMALiu, Xiao-Long; Liu, Jing-Feng#THERANOSTICS 9 (12): 3526-3540 2019vA NONCODING REGULATORY RNAS NETWORK DRIVEN BY CIRC-CDYL ACTS SPECIFICALLY IN THE EARLY STAGES HEPATOCELLULAR CARCINOMA Wei, Yanping#HEPATOLOGY 71 (1): 130-147 JAN 2020THYPOALBUMINEMIA PREDICTS THE OUTCOME OF COVID-19 INDEPENDENT OF AGE AND CO-MORBIDITYGHuang, Jiaofeng; Chen, Gongping; Zhu, Yueyong; Lin, Su7JOURNAL OF MEDICAL VIROLOGY 92 (10): 2152-2158 OCT 2020cDEEP LEARNING FOR AUTOMATED CONTOURING OF PRIMARY TUMOR VOLUMES BY MRI FOR NASOPHARYNGEAL CARCINOMA$Chen, Wei-Lin; Su, Bao-An; Liu, Feng#RADIOLOGY 291 (3): 677-686 JUN 2019™SAFETY AND ACTIVITY OF SINTILIMAB IN PATIENTS WITH RELAPSED OR REFRACTORY CLASSICAL HODGKIN LYMPHOMA (ORIENT-1): A MULTICENTRE, SINGLE-ARM, PHASE 2 TRIAL Hu, Jianda*LANCET HAEMATOLOGY 6 (1): E12-E19 JAN 20195COVID-19 IN POSTTRANSPLANT PATIENTS-REPORT OF 2 CASES*Huang, Jiaofeng;Wu, Yinlian;Chen, Gongping>AMERICAN JOURNAL OF TRANSPLANTATION 20 (7): 1879-1881 JUL 2020PCD22 CAR T-CELL THERAPY IN REFRACTORY OR RELAPSED B ACUTE LYMPHOBLASTIC LEUKEMIAFeng, Xiaoming$LEUKEMIA 33 (12): 2854-2866 DEC 2019\ALIROCUMAB REDUCES TOTAL NONFATAL CARDIOVASCULAR AND FATAL EVENTS THE ODYSSEY OUTCOMES TRIAL Lin, Jinxiu;HJOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY 73 (4): 387-396 FEB 5 2019�CIRCULAR RNA CIR< C-RANGAP1 REGULATES VEGFA EXPRESSION BY TARGETING MIR-877-3P TO FACILITATE GASTRIC CANCER INVASION AND METASTASIS{Lu, Jun; Wang, Yao-hui; Huang, Xiao-yan; Xu, Yu; Xie, Jian-wei; Wang, Jia-bin; Lin, Jian-xian; Chen, Qi-yue; Cao, Long-long%CANCER LETTERS 471: 38-48 FEB 28 2020gCIRCPAN3 MEDIATES DRUG RESISTANCE IN ACUTE MYELOID LEUKEMIA THROUGH THE MIR-153-5P/MIR-183-5P-XIAP AXISR Shang, Jin;Chen, Wei-Min;Wang, Zhi-Hong;Wei, Tian-Nan;Chen, Zhi-Zhong;Wu, Wen-Bing  ' (5 6E F*EXPERIMENTAL HEMATOLOGY 70: 42-54 FEB 2019§NEOADJUVANT MODIFIED FOLFOX6 WITH OR WITHOUT RADIATION VERSUS FLUOROURACIL PLUS RADIATION FOR LOCALLY ADVANCED RECTAL CANCER: FINAL RESULTS OF THE CHINESE FOWARC TRIAL7JOURNAL OF CLINICAL ONCOLOGY 37 (34): 3223-+ DEC 1 2019¯ERLOTINIB VERSUS GEMCITABINE PLUS CISPLATIN AS NEOADJUVANT TREATMENT OF STAGE IIIA-N2 EGFR-MUTANT NON-SMALL-CELL LUNG CANCER (EMERGING-CTONG 1103): A RANDOMIZED PHASE II STUDY7JOURNAL OF CLINICAL ONCOLOGY 37 (25): 2235-+ SEP 1 2019mASSESSMENT OF ENDOVASCULAR TREATMENT FOR ACUTE BASILAR ARTERY OCCLUSION VIA A NATIONWIDE PROSPECTIVE REGISTRY Yin, Congguo'JAMA NEUROLOGY 77 (5): 561-573 MAY 2020jALIROCUMAB IN PATIENTS WITH POLYVASCULAR DISEASE AND RECENT ACUTE CORONARY SYNDROME ODYSSEY OUTCOMES TRIALJJOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY 74 (9): 1167-1176 SEP 3 2019uPRESSURE-BASED BIOSENSOR INTEGRATED WITH A FLEXIBLE PRESSURE SENSOR AND AN ELECTROCHROMIC DEVICE FOR VISUAL DETECTION Liu, Xiaolong1ANALYTICAL CHEMISTRY 93 (5): 2916-2925 FEB 9 2021XEXOSOME-MEDIATED TRANSFER OF CIRCRNA CIRCNFIX ENHANCES TEMOZOLOMIDE RESISTANCE IN GLIOMAEDing, Chenyu;Yi, Xuehan;Wu, Xiyue;Wang, Desheng;Wu, Zanyi;Kang, Dezhi#CANCER LETTERS 479: 1-12 JUN 1 2020–CAMRELIZUMAB IN COMBINATION WITH APATINIB IN PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA (RESCUE): A FOR NONRANDOMIZED, OPEN-LABEL, PHASE II TRIAL6CLINICAL CANCER RESEARCH 27 (4): 1003-1011 FEB 15 2021�EFFICACY AND SAFETY OF LONG-TERM UNIVERSAL SALT IODIZATION ON THYROID DISORDERS: EPIDEMIOLOGICAL EVIDENCE FROM 31 PROVINCES OF MAINLAND CHINA Liu, Libin"THYROID 30 (4): 568-579 APR 1 2020;FATAL OUTCOME IN A LIVER TRANSPLANT RECIPIENT WITH COVID-19Huang, Jiao-Feng>AMERICAN JOURNAL OF TRANSPLANTATION 20 (7): 1907-1910 JUL 2020»ULTRASMALL PLATINUM NANOPARTICLES ENABLE DEEP TUMOR PENETRATION AND SYNERGISTIC THERAPEUTIC ABILITIES THROUGH FREE RADICAL SPECIES-ASSISTED CATALYSIS TO COMBAT CANCER MULTIDRUG RESISTANCE Yang, Da-Yun.CHEMICAL ENGINEERING JOURNAL 383: - MAR 1 2020 ENGINEERINGwSARS-COV-2 INFECTION INDUCES SUSTAINED HUMORAL IMMUNE RESPONSES IN CONVALESCENT PATIENTS FOLLOWING SYMPTOMATIC COVID-19Chen, Cunrong;+NATURE COMMUNICATIONS 12 (1): - MAR 22 2021nUSEFULNESS OF [GA-68]GA-DOTA-FAPI-04 PET/CT IN PATIENTS PRESENTING WITH INCONCLUSIVE [F-18]FDG PET/CT FINDINGSŽ Chen, HaojunÿZhao, LiangÿRuan, DanÿPang, YizhenÿHao, BingÿDai, YaqingÿWu, XiurongÿGuo, WeiÿFan, ChunleiÿWu, JingxunÿLin, QinÿSun, LongÿWu, Hua  " #/ 09 :E FQ RZ [g hs t| }† ‡QEUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING 48 (1): 73-86 JAN 2021ŠTREATMENT OF PATIENTS WITH RELAPSED OR REFRACTORY MANTLE-CELL LYMPHOMA WITH ZANUBRUTINIB, A SELECTIVE INHIBITOR OF BRUTONS TYROSINE KINASE7CLINICAL CANCER RESEARCH 26 (16): 4216-4224 AUG 15 2020lTWO-YEAR CLINICAL TRIAL OF THE LOW-CONCENTRATION ATROPINE FOR MYOPIA PROGRESSION (LAMP) STUDY PHASE 2 REPORT Tang, Shu Min'OPHTHALMOLOGY 127 (7): 910-919 JUL 2020`KNOWLEDGE, ATTITUDES, IMPACT, AND ANXIETY REGARDING COVID-19 INFECTION AMONG THE PUBLIC IN CHINALin, Yulan;Hu, Zhijian+FRONTIERS IN PUBLIC HEALTH 8: - MAY 27 2020SOCIAL SCIENCES, GENERAL–TUMOR MICROENVIRONMENT-ACTIVATED SELF-RECOGNIZING NANODRUG THROUGH DIRECTLY TAILORED ASSEMBLY OF SMALL-MOLECULES FOR TARGETED SYNERGISTIC CHEMOTHERAPYdLi, Yang;Lin, Jinyan;Cai, Zhixiong;Wang, Peiyuan;Luo, Qiang;Yao, Cuiping;Liu, Jingfeng;Liu, Xiaolong6JOURNAL OF CONTROLLED RELEASE 321: 222-235 MAY 10 2020…EVOLUTION OF HYPERVIRULENCE IN CARBAPENEM-RESISTANT KLEBSIELLA PNEUMONIAE IN CHINA: A MULTICENTRE, MOLECULAR EPIDEMIOLOGICAL ANALYSIS>JOURNAL OF ANTIMICROBIAL CHEMOTH<(ERAPY 75 (2): 327-336 FEB 2020“PRACTICE PATTERNS AND PERIOPERATIVE OUTCOMES OF LAPAROSCOPIC PANCREATICODUODENECTOMY IN CHINA A RETROSPECTIVE MULTICENTER ANALYSIS OF 1029 PATIENTSHuang, Heguang+ANNALS OF SURGERY 273 (1): 145-153 JAN 2021«GEFITINIB VERSUS VINORELBINE PLUS CISPLATIN AS ADJUVANT TREATMENT FOR STAGE II-IIIA (N1-N2) EGFR-MUTANT NSCLC: FINAL OVERALL SURVIVAL ANALYSIS OF CTONG1104 PHASE III TRIAL5JOURNAL OF CLINICAL ONCOLOGY 39 (7): 713-+ MAR 1 2021ªEFFICACY, SAFETY, AND CORRELATIVE BIOMARKERS OF TORIPALIMAB IN PREVIOUSLY TREATED RECURRENT OR METASTATIC NASOPHARYNGEAL CARCINOMA: A PHASE II CLINICAL TRIAL (POLARIS-02) Lin, XiaoYan5JOURNAL OF CLINICAL ONCOLOGY 39 (7): 704-+ MAR 1 2021HIBLP: AN XGBOOST-BASED PREDICTOR FOR IDENTIFYING BIOLUMINESCENT PROTEINSChen, Hua-DongECOMPUTATIONAL AND MATHEMATICAL METHODS IN MEDICINE 2021: - JAN 7 2021 MATHEMATICSvTHE GLIM CRITERIA AS AN EFFECTIVE TOOL FOR NUTRITION ASSESSMENT AND SURVIVAL PREDICTION IN OLDER ADULT CANCER PATIENTSGuo, Zeng-Qing-CLINICAL NUTRITION 40 (3): 1224-1232 MAR 2021pPREDICTING POSTOPERATIVE PERITONEAL METASTASIS IN GASTRIC CANCER WITH SEROSAL INVASION USING A COLLAGEN NOMOGRAM"Liu, Wenju;Chen, Feng;Lu, Jianping*NATURE COMMUNICATIONS 12 (1): - JAN 8 2021mASSESSMENT OF ROBOTIC VERSUS LAPAROSCOPIC DISTAL GASTRECTOMY FOR GASTRIC CANCER A RANDOMIZED CONTROLLED TRIALÄLu, Jun;Zheng, Chao-Hui;Xu, Bin-Bin;Xie, Jian-Wei;Wang, Jia-Bin;Lin, Jian-Xian;Chen, Qi-Yue;Cao, Long-Long;Lin, Mi;Tu, Ru-Hong;Huang, Ze-Ning;Lin, Ju-Li;Zheng, Hua-Long;Huang, Chang-Ming;Li, Ping +ANNALS OF SURGERY 273 (5): 858-867 MAY 2021®RHAMNETIN DECELERATES THE ELIMINATION AND ENHANCES THE ANTITUMOR EFFECT OF THE MOLECULAR-TARGETING AGENT SORAFENIB IN HEPATOCELLULAR CARCINOMA CELLS VIA THE MIR-148A/PXR AXISLi, Boan-FOOD & FUNCTION 12 (6): 2404-2417 MAR 21 2021AGRICULTURAL SCIENCESGJAK-INHIBITORS FOR CORONAVIRUS DISEASE-2019 (COVID-19): A META-ANALYSIS#LEUKEMIA 35 (9): 2616-2620 SEP 2021ÜCAMRELIZUMAB VERSUS PLACEBO IN COMBINATION WITH GEMCITABINE AND CISPLATIN AS FIRST-LINE TREATMENT FOR RECURRENT OR METASTATIC NASOPHARYNGEAL CARCINOMA (CAPTAIN-1ST): A MULTICENTRE, RANDOMISED, DOUBLE-BLIND, PHASE 3 TRIALLin, ShaojunÿHong, Jinsheng*LANCET ONCOLOGY 22 (8): 1162-1174 AUG 2021KFTO MODIFIES THE M6A LEVEL OF MALAT AND PROMOTES BLADDER CANCER PROGRESSION Zhou, Zhihua6CLINICAL AND TRANSLATIONAL MEDICINE 11 (2): - FEB 2021«A 36-WEEK MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, PHASE 3 CLINICAL TRIAL OF SODIUM OLIGOMANNATE FOR MILD-TO-MODERATE ALZHEIMERS DEMENTIAYe, Qinyong;He, Raoli3ALZHEIMERS RESEARCH & THERAPY 13 (1): - MAR 17 2021æMORBIDITY AND MORTALITY OF PATIENTS WHO UNDERWENT MINIMALLY INVASIVE ESOPHAGECTOMY AFTER NEOADJUVANT CHEMORADIOTHERAPY VS NEOADJUVANT CHEMOTHERAPY FOR LOCALLY ADVANCED ESOPHAGEAL SQUAMOUS CELL CARCINOMA A RANDOMIZED CLINICAL TRIALChen, ChunÿZheng, Bin&JAMA SURGERY 156 (5): 444-451 MAY 2021ŠLNCRNA ITGB8-AS1 FUNCTIONS AS A CERNA TO PROMOTE COLORECTAL CANCER GROWTH AND MIGRATION THROUGH INTEGRIN-MEDIATED FOCAL ADHESION SIGNALING% Lin, XiaotingÿZhuang, ShiwenÿYe, Feng  ,MOLECULAR THERAPY 30 (2): 688-702 FEB 2 2022 èlÿdkhˆ\O€ÅNSO°sr TUSMO-NS+T �yú^;SÑy'Yf[ „v\O€0   ÿ�~7 «óÚÐÛ » ÍÁ€ ^%éà1ïaü  dü©ñÒMbP?_*+‚€%,�Áƒ„&è?'è?(ð?)ð?¡" dà?à?œ&œ U} @}  @} €@} À@}  @}  @^°` °°„Ü 4 Ü „ 4 X�þÿÿÿþÿÿÿ„†þÿÿÿþÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿ„„°„¸ Ü„°` 4„ܰ܄¸ ` ý Aý Aý Bý Cý Cý Bý B~ Dð?ý Eý Fý G ý G ½D �@DˆŸ@~ D@ý E ý F ý G ý G ½D(€@D€Ÿ@~ D@ý Gý Fý Gý G ½Dw@DˆŸ@~ D@ý Gý Fý Gý G½D t@D„Ÿ@~ D@ý Gý Fý Gý G ½Dt@D€Ÿ@~ D@ý Gý Fý Gý G½D0s@DˆŸ@~ D@ý Gý Fý Gý G ½D0r@DtŸ@~ D @ý Gý Fý G ý G½DPp@D„Ÿ@~ D"@ý G!ý F"ý G#ý G ½ Dàn@DˆŸ@~ D$@ý G$ý F%ý G&ý G'½ D`n@D�Ÿ@~ D&@ý G(ý F)ý G*ý G½ D@n@DŒŸ@~ D(@ý G+ý F,ý G-ý G ½ Dàk@DŒŸ@~ D*@ý G.ý F/ý G0ý G ½ D`k@D|Ÿ@~ D,@ý G1ý F2ý G3ý G4½D k@DˆŸ@~ D.@ý G5ý F6ý G7ý G8½Dk@DˆŸ@~ D0@ý G9ý F:ý G;ý G ½D g@D�Ÿ@~ D1@ý G<ý F=ý G>ý G ½Dàf@D€Ÿ@~ D2@ý G?ý F@ý GAý G ½D€f@D€Ÿ@~ D3@ý GBý FCý GDý G ½De@D„Ÿ@~ D4@ý GEý FFý GGý G ½DÀd@D|Ÿ@~ D5@ý GHý FIý GJý G½D d@D”Ÿ@~ D6@ý GKý FLý GMý GN½D`d@DˆŸ@~ D7@ý GOý FPý GQý G ½D`d@D€Ÿ@~ D8@ý GRý F=ý GSý G ½D c@DŒŸ@~ D9@ý GTý FUý GVý GW½D c@D�Ÿ@~ D:@ý GXý FLý GYý GN½Dàb@DˆŸ@~ D;@ý GZý F[ý G\ý GN½D€b@D„Ÿ@~ D<@ý G]ý F^ý G_ý G ½D€b@DˆŸ@~ D=@ý G`ý Faý Gbý G ½D@b@D€Ÿ@~ D>@ý Gcý Fdý Geý G4½Db@DˆŸ@~ D?@ý Gfý Fgý Ghý G4½Db@D„Ÿ@×Dlb\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\ 4!°"„#„$%&'4(` )„*Ü+,°-4.Ü/Ü012Œ 34Ü5Ü6°7°89„:°;°<Œ =°>4?4~ D@@ý Giý Fjý Gký GN½ D a@DŒŸ@~ !D€@@ý !Glý !Fmý !Gný !GW½!D a@D�Ÿ@~ "DA@ý "Goý "Fpý "Gqý "G ½"D a@DŒŸ@~ #D€A@ý #Grý #Fsý #Gtý #G8½#D€a@DŒŸ@~ $DB@ý $Guý $Fvý $Gwý $G ½$DÀ`@D�Ÿ@~ %D€B@ý %Gxý %Fyý %Gzý %G ½%D `@D�Ÿ@~ &DC@ý &G{ý &F ý &G|ý &G ½&DÀ_@D�Ÿ@~ 'D€C@ý 'G}ý 'F~ý 'Gý 'G ½'D@_@D�Ÿ@~ (DD@ý (G€ý (F�ý (G‚ý (G ½(D_@DŒŸ@~ )D€D@ý )Gƒý )F„ý )G…ý )G ½)DÀ^@D�Ÿ@~ *DE@ý *G†ý *F‡ý *Gˆý *G‰½*D@^@D„Ÿ@~ +D€E@ý +GŠý +F‹ý +GŒý +G ½+D]@DŒŸ@~ ,DF@ý ,G�ý ,Fý ,GŽý ,G ½,D\@D�Ÿ@~ -D€F@ý -G�ý -F"ý -G�ý -G ½-D@[@DˆŸ@~ .DG@ý .G‘ý .F’ý .G“ý .G”½.D@[@DˆŸ@~ /D€G@ý /G•ý /F–ý /G—ý /G ½/DÀZ@DˆŸ@~ 0DH@ý 0G˜ý 0F™ý 0Gšý 0G ½0DZ@D�Ÿ@~ 1D€H@ý 1G›ý 1Fœý 1G�ý 1G ½1D€Y@DˆŸ@~ 2DI@ý 2Gžý 2Fý 2GŸý 2G ½2D@Y@DŒŸ@~ 3D€I@ý 3G ý 3F¡ý 3G¢ý 3G ½3D@X@D�Ÿ@~ 4DJ@ý 4G£ý 4F¤ý 4G¥ý 4G ½4D@X@DŒŸ@~ 5D€J@ý 5G¦ý 5F§ý 5G¨ý 5G ½5DÀW@D�Ÿ@~ 6DK@ý 6G©ý 6Fªý 6G«ý 6G'½6DÀV@D�Ÿ@~ 7D€K@ý 7G¬ý 7F­ý 7G®ý 7G ½7D€V@DŒŸ@~ 8DL@ý 8G¯ý 8F°ý 8G±ý 8G ½8D@V@DŒŸ@~ 9D€L@ý 9G²ý 9F³ý 9G´ý 9G ½9DU@D�Ÿ@~ :DM@ý :Gµý :F¶ý :G·ý :G ½:DÀT@DŒŸ@~ ;D€M@ý ;G¸ý ;F¹ý ;Gºý ;G ½;D@T@DŒŸ@~ <DN@ý <G»ý <F¼ý <G½ý <G ½<D@T@D�Ÿ@~ =D€N@ý =G¾ý =F¿ý =GÀý =G ½=D€S@DŒŸ@~ >DO@ý >GÁý >F@ý >GÂý >G ½>D€S@DŒŸ@~ ?D€O@ý ?GÃý ?F"ý ?GÄý ?G ½?D€S@DŒŸ@×Dl\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\@ÜAÜBÜC°D4EF„G` HÜIÜJKÜL°MNO4PQ4R„SÜTÜU4V4W„XŒ Y„Z` [ä \]~ @DP@ý @GÅý @FÆý @GÇý @G4½@DQ@D�Ÿ@~ AD@P@ý AGÈý AFý AGÉý AG ½ADQ@DŒŸ@~ BD€P@ý BGÊý BFËý BGÌý BGN½BD€O@D”Ÿ@~ CDÀP@ý CGÍý CFÎý CGÏý CG ½CDN@D�Ÿ@~ DDQ@ý DGÐý DFjý DGÑý DG ½DD€K@D”Ÿ@~ ED@Q@ý EGÒý EFÓý EGÔý EG8½ED€K@D�Ÿ@~ FD€Q@ý FGÕý FFÖý FG×ý FG ½FD€K@D�Ÿ@~ GDÀQ@ý GGØý GFÙý GGÚý GGÛ½GD€J@D�Ÿ@~ HDR@ý HGÜý HFÝý HGÞý HG ½HD€J@D”Ÿ@~ ID@R@ý IGßý IFàý IGáý IG ½ID€J@D”Ÿ@~ JD€R@ý JGâý JF°ý JGãý JG ½JD€I@D�Ÿ@~ KDÀR@ý KGäý KHåý KGæý KG ½KD€I@D�Ÿ@~ LDS@ý LGçý LHèý LGéý LGê½LD€G@D�Ÿ@~ MD@S@ý MGëý MFìý MGíý MG”½MDG@D�Ÿ@~ ND€S@ý NGîý NF’ý NGïý NG”½NDD@D�Ÿ@~ ODÀS@ý OGðý OFñý OGòý OG ½OD>@D”Ÿ@~ PDT@ý PGóý PF"ý PGôý PG ½PD=@D”Ÿ@~ QD@T@ý QGõý QFöý QG÷ý QG ½QD:@D”Ÿ@~ RD€T@ý RGøý RFùý RGúý RGû½RD:@D”Ÿ@~ SDÀT@ý SGüý SFýý SGþý SG ½SD:@D”Ÿ@~ TDU@ý TGÿý TFý TGý TG ½TD7@D”Ÿ@~ UD@U@ý UGý UFý UGý UG ½UD7@D”Ÿ@~ VD€U@ý VGý VFý VGý VG½VD5@D”Ÿ@~ WDÀU@ý WG ý WF™ý WG ý WG ½WD5@D”Ÿ@~ XDV@ý XI ý XF ý XG ý XG ½XD4@D”Ÿ@~ YD@V@ý YGý YFý YGý YG ½YD2@D”Ÿ@~ ZD€V@ý ZGý ZFý ZGý ZG4½ZD0@D”Ÿ@~ [DÀV@ý [Gý [Fý [Gý [G ½[D0@D”Ÿ@~ \DW@ý \Gý \Fý \Gý \G ½\D@D˜Ÿ@ý ]J¾]KKKKKL×@è D\\\\\\\\\\\\\\\\\\\\\\\\\\\\\>¶Z@<‹‹dJJJ™ å ]]ggÿÿÿÿD  þÿÿÿ þÿÿÿþÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿ šÕûn&æQKMÿÿÿÀÿÀÿÀÿÀÿÀÿÀÿÀÿÀÿÀÿÀÿÀÿÀÿÀÿÀÿÀÿàÀÿžçÀÿàÀÿàÀÿàÀÿÀÿÀÿžçàÀÿÀÿÀÿÀÿÀÿÀÿÀÿàÀÿÀÿàÀÿžçÀÿžçÀÿžçÀÿàÀÿàÀÿÀÿÀÿàÀÿàÀÿàÀÿàÀÿàÀÿàÀÿàÀÿàÀÿàÀÿàÀÿàÀÿàÀÿàÀÿàÀÿàÀÿàÀÿàÀÿàÀÿü€üÿÿÀÿüÿÿÀÿüÿÿÀÿüŸ€üÿÿÀÿüÿÿÀÿüŸÀÿüÿÿÀÿüŸÀÿüÿÿÀÿüÿÿÀÿüÿÿÀÿ÷ ÁA„. þÿà…ŸòùOh«‘+'³Ù0œ8€@H l x„° c'est la vie@,Ó¡ifØ@«ÿrfØWPS hˆ